High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2228-2231

  Zhuang, Yi ^a   Yin, Hai Tao ^b   Yin, Xia Li ^a   Wang, Jing ^a   Zhang, De Ping ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Meta analysis; NSCLC; P27; Prognosis

Indexed keywords

PROTEIN P27;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYSTEMATIC REVIEW; UPREGULATION;

ASIA; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; LUNG NEOPLASMS; PROGNOSIS; PUBLICATION BIAS; SURVIVAL ANALYSIS;

EID: 80053646086     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.08.018     Document Type: Article

References (43)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Alberg A.J., Ford J.G., Samet J.M., American College of Chest Physicians Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(3 Suppl.):29S-55S.
3. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
4. Kawaguchi T., Takada M., Kubo A., et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol 2010, 5(5):620-630.
5. Asmis T.R., Ding K., Seymour L., et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008, 26(1):54-59.
6. Hsu L.H., Chu N.M., Liu C.C., et al. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?. Lung Cancer 2009, 66(2):262-267.
7. Keyomarsi K., Tucker S.L., Buchholz T.A., et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002, 347:1566-1575.
8. Bloom J., Pagano M. Deregulated degradation of the CDK inhibitor p27 and malignant transformation. Semin Cancer Biol 2003, 13:41-47.
9. Katayose Y., Kim M., Rakkar A.N., Li Z., Cowan K.H., Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997, 57:5441-5445.
10. Levkau B., Koyama H., Raines E.W., et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1998, 1:553-563.
11. St Croix B., Florenes V.A., Rak J.W., et al. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med 1996, 2:1204-1210.
12. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 1996, 85:721-732.
13. Nakayama K., Ishida N., Shirane M., et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720.
14. Fero M.L., Rivkin M., Tasch M., et al. A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice. Cell 1996, 85:733-744.
15. Zhang H., Sun X.F. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Int J Oncol 2001, 19(1):49-52.
16. Juuti A., Nordling S., Louhimo J., Lundin J., von Boguslawski K., Haglund C. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Oncology 2003, 65(4):371-377.
17. Filipits M., Rudas M., Heinzl H., et al. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. Clin Cancer Res 2009, 15(18):5888-5894.
18. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
19. Catzavelos C., Tsao M.S., DeBoer G., Bhattacharya N., Shepherd F.A., Slingerland J.M. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res 1999, 59(3):684-688.
20. Jung J.H., Park G., Lee M.A., et al. Expressions of cyclin E-pathway proteins (cyclinE, cdk2, p21, p27, p57) and their prognostic significance in non-small cell lung carcinomas. Korean J Pathol 2006, 40:24-31.
21. Gao A.F., Qiu X.S., Wang L.P., Feng S.G. Expression and degradation of p27 protein in NSCLC and its correlation with prognosis. Railway Med J 2001, 29(6):359-362. (Chinese).
22. Anami Y., Iijima T., Suzuki K., et al. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol 2009, 4(8):951-958.
23. Esposito V., Baldi A., De Luca A., et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997, 57(16):3381-3385.
24. Hirabayashi H., Ohta M., Tanaka H., et al. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53. J Surg Oncol 2002, 81(4):177-184.
25. Hommura F., Dosaka-Akita H., Mishina T., et al. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 2000, 6(10):4073-4081.
26. Ishihara S., Minato K., Hoshino H., et al. The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. Lung Cancer 1999, 26(3):187-194.
27. Jo B.G., Cho S.R., Chun B.K. Prognostic significance of cyclin E and p27 in stage I non-small cell lung cancer. Korean J Thorac Cardiovasc Surg 2003, 36:7-14.
28. Liu W.J., He M.Q., Liu X.M., et al. Expressions of anti-oncogene PTEN and P27 in the non-small cell lung cancer related with the differentiation and functional prognosis of lung cancer. Chin J Clin Rehabil 2005, 9(10):130-132. (Chinese).
29. Sterlacci W., Fiegl M., Hilbe W., et al. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients. J Thorac Oncol 2010, 5(9):1325-1336.
30. Tsukamoto S., Sugio K., Sakada T., Ushijima C., Yamazaki K., Sugimachi K. Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer. Lung Cancer 2001, 34(1):83-90.
31. Yoo J., Jung J.H., Lee M.A., Seo K.J., Shim B.Y., Kim S.H. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci 2007, 22:318-325.
32. Zhu C.Q., Blackhall F.H., Pintilie M., et al. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Clin Cancer Res 2004, 10(6):1984-1991.
33. Mitchell E.P. Prognostic impact of race and ethnicity in the treatment of colorectal cancer. Med Clin North Am 2005, 89(5):1045-1057.
34. Perkins P., Cooksley C.D., Cox J.D. Breast cancer. Is ethnicity an independent prognostic factor for survival?. Cancer 1996, 78(6):1241-1247.
35. Ou S.H., Ziogas A., Zell J.A. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 2009, 4(9):1083-1093.
36. Ou S.H., Zell J.A., Ziogas A., Anton-Culver H. Prognostic factors for survival in stage I nonsmall cell lung cancer patients. Cancer 2007, 110:1532-1541.
37. Zell J.A., Ou S.H., Ziogas A., Anton-Culver H. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Cancer 2008, 112:136-143.
38. Ou S.H., Zell J.A. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008, 3:216-227.
39. Ahn M.J., Lee J., Park Y.H., et al. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era. J Thorac Oncol 2010, 5(8):1185-1196.
40. Kawaguchi T., Matsumura A., Fukai S., et al. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol 2010, 5(7):1001-1010.
41. Radzikowska E., Glaz P., Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002, 13(7):1087-1093.
42. Tan Y.K., Wee T.C., Koh W.P., et al. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer 2003, 40(3):237-246.
43. Koopman L., van der Heijden G.J., Hoes A.W., et al. Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. Int J Technol Assess Health Care 2008, 24(3):358-361.